基本信息
浏览量:3
职业迁徙
个人简介
His major research interests lie in the area of pharmacokinetics. He has a general interest in the subject as a whole but has a special interest in data analysis and interpretation. He collaborates with members of the pharmacokinetic group in Manchester and also with other scientists in industry and academia throughout Europe. His current activities revolve around population pharmacokinetics. People involved in the drug development process are becoming increasingly aware of the importance of studying the pharmacokinetic and pharmacodynamics of the drug in the population interest as soon as possible.
He is a member on various committees promoting research including the United Kingdom Pharmacokinetic Discussion Group and is a member of the management committee of COST B25.
He is a member on various committees promoting research including the United Kingdom Pharmacokinetic Discussion Group and is a member of the management committee of COST B25.
研究兴趣
论文共 247 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Heliyonno. 3 (2024): e24762-e24762
Y. Cleary,H. Kletzl,P. Grimsey,K. Heinig,K. Ogungbenro, H. Silber--Baumann,N. Frey,L. Aarons,A. Galetin,M. Gertz
CLINICAL PHARMACOLOGY & THERAPEUTICS (2023): S63-S63
引用0浏览0引用
0
0
European Journal of Pharmaceutics and Biopharmaceutics (2023): 78-88
Yumi Cleary,Heidemarie Kletzl,Paul Grimsey,Katja Heinig,Kayode Ogungbenro, Hanna Elisabeth Silber Baumann,Nicolas Frey,Leon Aarons,Aleksandra Galetin,Michael Gertz
Clinical Pharmacokineticsno. 6 (2023): 891-904
The journal of pharmacology and experimental therapeutics/The Journal of pharmacology and experimental therapeuticsno. 1 (2023): 44-54
CPT: pharmacometrics & systems pharmacologyno. 11 (2023): 1640-1652
CLINICAL PHARMACOLOGY & THERAPEUTICS (2022): S70-S70
引用0浏览0引用
0
0
加载更多
作者统计
#Papers: 247
#Citation: 5469
H-Index: 36
G-Index: 59
Sociability: 7
Diversity: 0
Activity: 1
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn